News

Exciting New Cardiovascular Technician Program by HCC

Exciting New Cardiovascular Technician Program by HCC

Innovative Cardiovascular Technician Apprenticeship Program

Howard Community College (HCC) and MedStar Health are thrilled to announce the launch of a new Cardiovascular Technician (CV Tech) Registered Apprenticeship Program, set to begin in January 2026. This unique partnership will enable 15 apprentices to gain experience by working full-time at MedStar Health while pursuing their Cardiovascular Technology certificate at HCC.

Advantages for Students

The apprenticeship offers numerous benefits for aspiring technicians. As full-time employees of MedStar Health, apprentices will have their full tuition, fees, and books covered, allowing them to focus on their education without the additional financial burden. The program, lasting between 18 to 24 months, uniquely combines classroom instruction with on-the-job training, allowing students to learn in real-time while earning a salary.

Meeting Workforce Demands

This initiative emerges from an increasing demand for skilled cardiovascular technicians within MedStar hospitals. By creating this program, HCC aims to position itself as a leader in registered apprenticeships nationwide. It marks the first instance where a community college in the United States—and specifically Maryland—will sponsor such a program, setting a significant precedent in education and industry collaboration.

Support from State Officials

The announcement was met with enthusiasm by local government officials. Maryland Secretary of Labor Portia Wu expressed her congratulations to HCC and MedStar Health, acknowledging the program's potential to open new career paths for Marylanders while simultaneously addressing the critical need for qualified healthcare professionals in the community.

The Importance of Community Partnerships

MedStar Health's collaboration with HCC highlights the profound impact community partnerships can have on workforce development. This effort builds upon their existing relationship which has seen the successful implementation of the Surgical Technician Registered Apprenticeship Program. With this new initiative, they aim to create a sustainable pipeline of trained cardiovascular technicians, ensuring that local healthcare facilities can meet growing patient needs.

Career Opportunities

Upon successfully completing the CV Tech apprenticeship, graduates will earn Invasive Cardiovascular Technology Certification. This credential will empower them to pursue fulfilling careers in healthcare, where there is a consistent demand for skilled technicians. The accessibility of this program opens doors for many, particularly in a field where job satisfaction and stability are key components.

HCC’s Commitment to Student Success

Howard Community College’s long-standing dedication to education is evident in its continued efforts to innovate and establish programs that align with the needs of both students and employers. Since its establishment in 1970, HCC has consistently provided avenues for nearly 22,000 students each year to gain valuable skills and knowledge through a variety of degree and certificate programs.

HCC's recognition through awards such as the Malcolm Baldrige National Quality Award underscores its commitment to excellence and a quality educational experience. The launch of the CV Tech apprenticeship exemplifies this dedication to developing routes that connect academic learning with career opportunities.

Looking Ahead

The announcement of the Cardiovascular Technician Apprenticeship Program highlights an exciting future for healthcare education at Howard Community College. As the first of its kind in the region, it promises to forge pathways for students seeking impactful and high-demand careers. By targeting workforce shortages in the healthcare sector, this program holds the potential for substantial community benefits and lifelong career advancements.

Frequently Asked Questions

What is the Cardiovascular Technician Apprenticeship Program?

It is a new apprenticeship program by HCC and MedStar Health that allows students to work full-time while pursuing their Cardiovascular Technology certification.

How long does the apprenticeship program last?

The program duration is between 18 to 24 months, combining on-the-job training with classroom instruction.

Who will pay for the education costs?

MedStar Health will cover the full tuition, fees, and books for the apprentices.

What certification will apprentices earn?

Upon completion, apprentices will receive an Invasive Cardiovascular Technology Certification.

Is this program unique to HCC?

Yes, HCC is the first community college in the U.S. and Maryland to sponsor a cardiovascular technician apprenticeship, setting a nationwide precedent.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 203

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 346

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 209

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 409

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 181

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 232

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 319

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 407

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 317

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 273

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading

Top 5 Most Recently Viewed Articles

Medtronic's Upcoming Financial Results and Company Innovations

Updated Category News Views 340

Medtronic to Report First Quarter Financial Results Medtronic plc (NYSE: MDT), a prominent leader in healthcare technology, is set to announce its financial outcomes for the first quarter of fiscal year 2026. The results will encapsulate a crucial period of growth and innovation as the company continues to transform healthcare solutions. The report will be released soon,...

Continue Reading
Exploring Alignment Healthcare's Transformative Approach to Care

Updated Category News Views 167

Alignment Healthcare's Vision for Senior Care Alignment Healthcare, Inc. (NASDAQ: ALHC), known for its proactive approach towards senior care, continues to transform how healthcare services are delivered. Their distinctive focus is on empowering members to lead fulfilling lives as they age, ensuring they receive high-quality, low-cost care. Presentation at the J.P. Morgan...

Continue Reading
Exploring the Promise of MandalaChain's Innovative Approach

Updated Category News Views 176

Introduction to MandalaChain's Vision In the rapidly evolving world of digital currencies and blockchains, MandalaChain is making a significant impact with its innovative approach. The core of this exciting ecosystem lies in its primary token, KPG. Currently, KPG tokens are priced at $0.027 during the presale, which has successfully garnered $2.3 million from various...

Continue Reading
Monthly Dividend Announcement for First Trust Income Fund

Updated Category News Views 52

First Trust Intermediate Duration Preferred & Income Fund Announces Monthly Distribution First Trust Intermediate Duration Preferred & Income Fund (the "Fund") (NYSE: FPF) has announced its latest monthly common share distribution of $0.1375 per share. This distribution reflects the Fund's ongoing commitment to providing income to its shareholders. Shareholders can expect...

Continue Reading
Molly Troupe Joins Clear Water Distilling for Innovative Spirits

Updated Category News Views 358

Trailblazing Master Distiller Molly Troupe Joins Clear Water Distilling Co. Award-Winning Industry Leader Brings Innovative Spirit and Deep Expertise to Utah-Based Distillery. Clear Water Distilling Co. is thrilled to announce Molly Troupe's addition as Master Distiller. Known for her remarkable precision, vision, and strong leadership qualities, she brings extensive...

Continue Reading